United States - English - NLM (National Library of Medicine)

citra labs llc - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl) - anhydrous citric acid 14 g in 30 ml - tricitrasol ® anticoagulant sodium citrate concentrate, 46.7% trisodium citrate, is an anticoagulant used in granulocytapheresis procedures (granulocyte collection by apheresis). just prior to performing granulocytapheresis, aseptically add 30 ml of tricitrasol ® to 500 ml of the 6% solution of hydroxyethyl starch (hes), e.g. hespan ® 2-8 . agitate the resultant solution for 1 minute to assure a uniform concentration of anticoagulant. the resultant solution of tricitrasol ® and 6% solution of hes contains the following concentration depending upon the volume used: the tricitrasol ® /hes solution is stable for up to 24 hours at room temperature after mixing. refer to the manufacturer's operator's manual of the apheresis medical device for the directions to perform the granulocytapheresis procedure. not for direct intravenous infusion.

United States - English - NLM (National Library of Medicine)

haemonetics corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl) - anhydrous citric acid 40 mg in 1 ml

United States - English - NLM (National Library of Medicine)

csl plasma inc. - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl) - anticoagulant sodium citrate 4% w/v solution usp is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures. [see dosage and administration (2).] do not infuse anticoagulant sodium citrate 4% w/v solution usp directly to the donor. anticoagulant sodium citrate 4% w/v solution usp has not been adequately studied in controlled clinical trials with specific populations.

United States - English - NLM (National Library of Medicine)

terumo bct, ltd - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl) - sodium citrate 4% w/v anticoagulant solution is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures. [see dosage and administration (2).] do not infuse sodium citrate 4% w/v anticoagulant solution usp directly to the donor. sodium citrate 4% w/v anticoagulant solution usp has not been adequately studied in controlled clinical trials with specific populations.

United States - English - NLM (National Library of Medicine)

terumo bct, ltd - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl) - sodium citrate 4% w/v anticoagulant solution usp is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures. [see dosage and administration (2).] do not infuse sodium citrate 4% w/v anticoagulant solution usp directly to the donor. sodium citrate 4% w/v anticoagulant solution usp has not been adequately studied in controlled clinical trials with specific populations.

United States - English - NLM (National Library of Medicine)

alva-amco pharmacal companies, inc. - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), dextrose (unii: iy9xdz35w2) (dextrose - unii:iy9xdz35w2), fructose (unii: 6yss42vsev) (fructose - unii:6yss42vsev) - trisodium citrate dihydrate .921 g in 15 ml - for the relief of nausea associated with upset stomach, including that due to overindulgence in food or drink. do not use if you have hereditary fructose intolerance (hfi).  this product contains fructose. - you have diabetes because this product contains sugar - are on a sodium-restricted diet. stop use and ask a doctor if nausea lasts more than two weeks or recurs frequently.

United States - English - NLM (National Library of Medicine)

terumo corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - trisodium citrate dihydrate 26.3 g in 1000 ml - 1.1. read these instructions carefully before use. 1.2. rx only. 1.3. intended for the collection, processing and preservation of whole blood and blood components. not intended for direct intravenous infusion. 1.4. for the collection of 450 ml ±10% or 500 ml ±10% whole blood. 1.5. integral diversion blood sampling arm is intended to divert and obtain donor samples for laboratory testing prior to collection of the whole blood unit. 1.6. for further processing, use standard component processing techniques. this device is for use by trained individuals. intended use the donorcare® needle guard is incorporated onto the donor tubing to shield the needle immediately after withdrawal from the donor. single use only. preparation 1. move the donorcare on the tubing ensuring that it slides easily and the arrow is pointing toward the needle hub. 2. ensure that the three lock points on the donorcare are locked closed. whole blood collection 3. perform the phlebotomy as per your institution's standard operating procedures

United States - English - NLM (National Library of Medicine)

terumo corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, unspecified form (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - trisodium citrate dihydrate 26.3 g in 1000 ml - issued 6/03 teruflex® blood bag system with diversion blood sampling arm® cpd/optisol® solution read these instructions carefully before use. rx only. the diversion blood sampling arm™ is intended to divert and collect blood for obtaining donor test samples. • for single use only. sterile and non-pyrogenic fluid path. sterilized by steam. • intended for the collection, processing and preservation of human blood and components. precautions • do not use unless the solutions are clear. • avoid excessive heat and direct sunlight. protect from freezing. • recommended storage conditions: room temperature (15-30°c/59-86°f). • the blood bag configuration is specified on the blister pack label. caution do not use a dielectric tube sealer to seal the tubing while the needle is connected to the donor's body unless it is approved for such a purpose. instructions for blood collection: use aseptic technique materials needed: venoject® ll tube holder (code p-1316r) or eq

United States - English - NLM (National Library of Medicine)

terumo corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, unspecified form (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - trisodium citrate dihydrate 26.3 g in 1000 ml - issued 8/96 teruflex® blood bag system with blood sampling arm® cpd/optisol® solution read these instructions carefully before use. instructions for blood collection: use aseptic technique materials needed: venoject® ll tube holder (code p-1316r) venoject® ll multi-sample luer adapter (code mn *2000) venoject® ll plastic blood collection tubes (or equivalent glass or plastic evacuated blood collection tube) 1. confirm that all numbered tubing of each blood bag unit contains segment numbers. 2. make a loose knot in donor tubing below "y" unless alternate methods are used to seal tubing. 3. clamp donor tubing. 4. suspend primary bag as far as possible below the donor's arm. 5. apply blood pressure cuff or tourniquet to donor's arm. disinfect site of phlebotomy. if blood pressure cuff is used, inflate cuff to approximately 60 mmhg. 6. remove needle protector and perform phlebotomy. remove clamp to permit blood flow into primary bag. caution do not touch needle aft

United States - English - NLM (National Library of Medicine)

terumo corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, unspecified form (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - trisodium citrate dihydrate 26.3 g in 1000 ml - revised 8/96 teruflex® blood bag system cpd/optisol® solution read these instructions before use. instructions for blood collection: use aseptic technique 1. confirm that all numbered tubing of each blood bag unit contains segment numbers. 2. make a loose knot in the donor tubing approximately 10 cm from needle unless alternate methods are used to seal tubing. 3. clamp donor tubing. 4. suspend primary bag as far as possible below the donor's arm. 5. apply blood pressure cuff or tourniquiet to donor's arm. disinfect site of phlebotomy. if blood pressure cuff is used, inflate cuff to 60 mmhg. 6. remove needle protector and perform phlebotomy. remove clamp to permit blood flow into primary bag. caution do not touch needle after removing the needle protector. 7. appropriately secure donor tubing to donor's arm. 8. mix blood with anticoagulant at several intervals during collection. 9. collect labeled volume of blood (+/- 10%). 10. tighten knot firmly after collection. clamp betwe